Search for Clinical Trial Results

Sponsored By

Atypical Hemolytic Uremic Syndrome - 18 Studies Found

Status Study
Completed Study Name: An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Condition: Atypical Hemolytic-Uremic Syndrome
Date: 2010-08-31
Interventions: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following
Completed Study Name: An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
Condition: Atypical Hemolytic-Uremic Syndrome
Date: 2010-08-31
Interventions: Drug: Eculizumab Fixed dosing is based on body weight cohorts. Adjustment of dose to accommodate patient
Completed Study Name: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome
Date: 2009-02-03
Interventions: Drug: eculizumab All patients received open-label eculizumab administered intravenously on the following
Completed Study Name: Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease
Condition: Atypical Hemolytic Uraemic Syndrome.
Date: 2009-06-29
Not yet recruiting Study Name: Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
Date: 2017-04-24
Interventions: Biological: ALXN1210 Single loading dose on Day 1, followed by regular maintenance dosing beginning on D
Completed Study Name: A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
Date: 2012-11-13
Recruiting Study Name: Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Date: 2015-10-05
Interventions: Drug: eculizumab eculizumab discontinuation
Terminated Study Name: aHUS Observational Long Term Follow-Up
Condition: Atypical Hemolytic Uremic Syndrome
Date: 2012-01-18
Recruiting Study Name: Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry
Condition: Atypical Hemolytic-Uremic Syndrome
Date: 2012-01-18
Terminated Study Name: Complement Inhibition in aHUS Dialysis Patients
Condition: Atypical Hemolytic Uremic Syndrome
Date: 2015-05-26
Interventions: Drug: CCX168
Next >>>